HomeLIXT • NASDAQ
add
Lixte Biotechnology Holdings Inc
Previous close
$1.99
Day range
$2.00 - $2.05
Year range
$1.55 - $4.42
Market cap
4.59M USD
Avg Volume
101.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.01M | -39.57% |
Net income | -1.01M | 39.41% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.60M | -10.91% |
Total assets | 2.67M | -13.81% |
Total liabilities | 421.46K | 4.68% |
Total equity | 2.25M | — |
Shares outstanding | 2.25M | — |
Price to book | -3.55 | — |
Return on assets | -80.64% | — |
Return on capital | -93.92% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -1.01M | 39.41% |
Cash from operations | -819.04K | 30.32% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -819.04K | 30.32% |
Free cash flow | -441.44K | 20.03% |
About
Founded
2005
Website
Employees
3